ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure
This clinical trial aims to determine whether a ReDS-guided treatment strategy is superior to the current standard of care for adults hospitalized with heart failure. Additionally, the study will evaluate the safety and cost-effectiveness of this approach.
The study seeks to answer the following key questions:
1. Does the ReDS-guided strategy reduce the risk of cardiovascular events during the first month following hospital discharge?
2. What is the safety profile of this treatment strategy?
Researchers will compare the ReDS-based strategy against the current standard of care. All participants will:
* Undergo daily assessments using the ReDS device throughout their hospitalization.
* Attend two follow-up visits post-discharge, scheduled at 2 weeks and 30 days.
Gender: All
Ages: 18 Years - Any
Acute Heart Failure (AHF)
Heart Failure (for Example, Fluid Overload)
Heart Failure Hospitalization